Abstract
In recent decades, tertiary hospitals in various regions of the world have faced a significant increase in cases of invasive infections caused by Candida spp. These infections have high rates of morbidity and mortality, and early identification of affected patients often fails. As a result, prophylactic and empirical antifungal therapeutic practices have been increasingly employed. Howeve…